This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ferrer Internacional, S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Pablo Martín Sáiz in Pharmaceutical Formulations
Introduction
Pablo Martín Sáiz is an accomplished inventor based in Sant Cugat del Vallès, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of multilayer solid dosage forms. His innovative work focuses on enhancing the therapeutic efficacy of medications through advanced formulations.
Latest Patents
Pablo holds a patent for a multilayer pharmaceutical or nutraceutical solid dosage form that comprises pyrimidine and/or purine derivatives along with B-group vitamins. The patent details a novel approach to creating these dosage forms, which are designed to improve the treatment and prevention of peripheral neuropathy. This invention not only outlines the composition but also provides three methods for producing these multilayer forms, showcasing his expertise in pharmaceutical technology.
Career Highlights
Pablo is currently associated with Ferrer Internacional, S.A., a company known for its commitment to innovation in healthcare. His role at Ferrer has allowed him to apply his inventive skills in a practical setting, contributing to the development of effective pharmaceutical solutions. His work is characterized by a strong focus on improving patient outcomes through innovative drug formulations.
Collaborations
Pablo collaborates with Berta Fernández Mollar, who is also involved in the pharmaceutical sector. Their partnership exemplifies the collaborative spirit in research and development, which is essential for driving innovation in the industry.
Conclusion
Pablo Martín Sáiz is a notable inventor whose work in multilayer pharmaceutical formulations has the potential to significantly impact the treatment of peripheral neuropathy. His contributions to the field reflect a dedication to advancing healthcare through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
